EichorEICHOR
Condition: Puberty Precocious Central Synced from ClinicalTrials.gov · August 04, 2026

Recruiting studies: Puberty Precocious Central

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of Leuprorelin 1-Month (4-Week) Formulation in Children With Central Precocious Puberty
Phase 4 · 1 location(s) · LG Chem · NCT07710430IDMet (RaDiCo Cohort) (RaDiCo-IDMet)
Phase N/A · 20 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT05945576Idiopathic Central Precocious Puberty and Associated Neurodevelopmental Syndromes and Pathologies: Evaluation of Frequen
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06720844
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.